ioRad Mini Protean II Cell at 1 mA cm2 membrane in 10% methanol, 192 mM gly cine, and 25 mM Tris, pH 8. 2. Membranes were blocked with 4% non fat milk powder in PBS 0. 05% Tween for 4 h. Primary antibodies were applied in blocking buffer and incubated at room temperature sellekchem overnight. Antibo dies against caspases and ER stress related proteins were included in antibody sampler kits purchased from Cell Signalling, NEB, Frankfurt, Germany. Polyclonal antibo dies against PARP, bak, bid, bcl L, LC3, and CO IV were purchased separately from Cell Signalling. Antibodies against ATF3, b actin, BiP, mcl 1, and p53 were from SantaCruz Bio tech. Monoclonal cell cycle regu latory antibodies were included in a cell cycle antibody sampler kit from BD Biosciences, Heidelberg, Germany.

RT PCR analysis RNA was e tracted from cells using the Nucleospin RNA II kit. Reverse transcription was performed with M MLV reverse tran scriptase, as recom mended by the supplier. PCR was carried out in an Eppendorf Mastercycler with GoTaq. Primer pairs were used to amplify a 402 bp C terminal fragment of mcl 1 and a 640 bp fragment. The difference between MCL1S and MCL1L is generated by alternative splicing within this region. PCR cycling was performed after a 5 min initiation at 94 C with 26 28 cycles of 1 min at 94 C, 1 min at 57 C, and 2 min at 72 C, followed by a 5 min e tension at 72 C. Mitochondria isolation Cells were collected by centrifugation at 750 g for 5 min, washed once with PBS, and resuspended in five volumes of buffer A as described.

The cells were homogenized in a 2 ml glass Dounce homogenizer using the loose fit pestle for 4 strokes and the tight fit pestle for an additional 10 strokes. The homogenates were centrifuged Dacomitinib at 750 g for 10 min at 4 C to remove the nuclei. Supernatants were centrifuged at 10,000 g for 15 min at 4 C. The crude mitochondrial pellet fractions were dissolved in Western blot sample buffer, and the supernatants were mi ed with 2�� sample buffer. For caspase cleavage analysis, enriched mitochondria were resuspended in 20 ul of buffer A and incubated for 1 h with 1 unit of recombinant human caspase 3 or caspase 8. Results Nelfinavir induces apoptosis in human leukemia cells at concentrations that have limited effects on normal bone marrow cells The human leukemia cell lines HL60, IM9 and Jurkat were incubated with nelfinavir at concentrations between 0 and 10 ug ml.

Cell survival was then analyzed by a chemiluminescent ATP assay. At concentrations between 4 and 10 ug ml, nelfinavir induced cell death in all three leukemia cells tested, showing an ED50 of 5. 6 7 ug ml and an ED90 of 9 10 ug ml, depending on the cell line tested. In human bone marrow cells tested e vivo under the same conditions, 10 ug ml nelfinavir selleck chem inhibitor had only a slight effect on cell survival. However, BMC were not completely unaffected by nelfinavir, and higher nelfi navir concentrations were indeed able to induce BMC cell death. In leukemia cells treated with 8 ug ml nelfinavir,